M. Taşkıran Et Al. , "Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.," Fundamental & clinical pharmacology , no.1, 2024
Taşkıran, M. Et Al. 2024. Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.. Fundamental & clinical pharmacology , no.1 .
Taşkıran, M., Taskiran, S. Y., Unal, G., Bozkurt, N. M., & Golgeli, A., (2024). Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.. Fundamental & clinical pharmacology , no.1.
Taşkıran, MEHMET Et Al. "Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.," Fundamental & clinical pharmacology , no.1, 2024
Taşkıran, MEHMET Et Al. "Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.." Fundamental & clinical pharmacology , no.1, 2024
Taşkıran, M. Et Al. (2024) . "Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.." Fundamental & clinical pharmacology , no.1.
@article{article, author={MEHMET TAŞKIRAN Et Al. }, title={Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats.}, journal={Fundamental & clinical pharmacology}, year=2024}